Tag

The Medellin clinic, with a grand opening planned for December 8, 2020, will support Khiron´s goal of expanding regional access to the firm’s clinical services and medical cannabis products for patients.

Khiron Life Sciences Corp. ( (TSXV: KHRN), (OTCQB: KHRNF), (Frankfurt: A2JMZC), has announced that its wholly-owned clinic network, the Latin American Institute of Neurology and the Nervous System (“ILANS”), has partnered with Colombian health insurance company...

Khiron CEO Alvaro Torres says adding Fox to the board of directors “significantly expands our scope of influence and relationships within the Latin American market.”

Khiron will grow cannabis strains chosen to target “patients identified as having unmet medical needs" within Colombia and Latin America.